Clinical Therapeutics

Editorial comment
pp. 645-645(1)
Author: Walson P.D.

Matching treatment to pathophysiology in type 2 diabetes
pp. 646-659(14)
Author: Gerich J.E.

A review of omeprazole use in the treatment of acid-related disorders in children
pp. 660-679(20)
Authors: Zimmermann A.E.; Ken Walters J.; Katona B.G.; Souney P.F.; Levine D.

Oxcarbazepine, an antiepileptic agent
pp. 680-700(21)
Authors: Kalis M.M.; Huff N.A.

Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy
pp. 701-714(14)
Authors: Dorinsky P.M.; Edwards L.D.; Yancey S.W.; Rickard K.A.

Tolerability of antihypertensive drugs in a community-based setting
pp. 715-726(12)
Authors: Gregoire J.-P.; Moisan J.; Guibert R.; Ciampi A.; Milot A.; Cote I.; Gaudet M.

Initiation of nonselective alpha₁-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study
pp. 727-743(17)
Authors: Chrischilles E.; Rubenstein L.; Chao J.; Kreder K.J.; Gilden D.; Shah H.

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo
pp. 744-752(9)
Authors: Jamerson B.D.; Nides M.; Jorenby D.E.; Donahue R.; Garrett P.; Andrew Johnston J.; Fiore M.C.; Rennard S.I.; Leischow S.J.

A comparison of the effects of saliva output of oxybutynin chloride and tolterodine tartrate
pp. 753-760(8)
Authors: Chancellor M.B.; Appell R.A.; Sathyan G.; Gupta S.K.

Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study
pp. 761-770(10)
Authors: Luzza F.; Giglio A.; Ciliberto E.; Belmonte A.; Cavaliere C.; Sacca N.; Frandina C.; Fiocca R.; Trimboli V.; Pallone F.